Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6943-6949

  Liu, Jian ^a   Chen, Lujun ^a   Deng, Haifeng ^a   Xu, Bin ^a   Li, Min ^a   Zheng, Xiao ^a   Wu, Changping ^a   Jiang, Jingting ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Esophageal cancer; Immunohistochemistry; Tissue microarray

Indexed keywords

CADHERIN; CDH1 PROTEIN, HUMAN; TUMOR MARKER; VIMENTIN;

CANCER STAGING; CHEMISTRY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TISSUE MICROARRAY; TUMOR VOLUME;

CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TISSUE ARRAY ANALYSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84912097536     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zeisberg M and Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-37.
2. Kalluri R and Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-84.
3. Thiery JP and Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
4. Kalluri R and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
5. Pohl M, Radacz Y, Pawlik N, Schoeneck A, Baldus SE, Munding J, Schmiegel W, Schwarte-Waldhoff I and Reinacher-Schick A. SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. Anticancer Res 2010; 30: 2603-13.
6. Kalluri R and Weinberg RA. The basics of epithelial- mesenchymal transition. J Clin Invest 2009; 119: 1420-8.
7. Falk GW. Risk factors for esophageal cancer development. Surg Oncol Clin N Am 2009; 18: 469-85.
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
9. Chen L, Luo G, Tan Y, Wei J, Wu C, Zheng L, Zhang X and Xu N. Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem 2010; 112: 233-9.
10. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, Shan BE, Lu BF and Zhang XG. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011; 60: 1047-55.
11. Cowling VH and Cole MD. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation. Oncogene 2007; 26: 3582-6.
12. Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H and Becker KF. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer 2008; 98: 489-95.
13. Chen L, Di D, Luo G, Zheng L, Tan Y, Zhang X and Xu N. Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res 2010; 30: 4363-8.
14. Chen L, Sun J, Wu H, Zhou S, Tan Y, Tan M, Shan B, Lu B and Zhang X. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011; 60: 1047-55.
15. Zhong B, Wang T, Lun X, Zhang J, Zheng S, Yang W, Li W, Xiang AP and Chen Z. Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis. Cancer Cell Int 2014; 14: 57.
16. Geiger TR and Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009; 1796: 293-308.
17. Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009; 15: 195-206.
18. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15.
19. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Molr Cell Biol 2002; 3: 155-66.
20. Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R and Ralhan R. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer 2009; 9: 325.
21. Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta A, Isohata N, Saeki N, Taniguchi H, Sakamoto H, Shimoda T, Tani T, Yoshida T, Sasaki H. Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer 2009; 100: 389-98.
22. Tomaskovic-Crook E, Thompson EW and Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 2009; 11: 213.
23. Miura N, Yano T, Shoji F, Kawano D, Takenaka T, Ito K, Morodomi Y, Yoshino I and Maehara Y. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Anticancer Res 2009; 29: 4099-106.
24. Mise BP, Telesmanic VD, Tomic S, Sundov D, Capkun V and Vrdoljak E. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer. Pathol Oncol Res 2014; [Epub ahead of print].
25. Wu J, Zhang JR and Qin J. Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues. Int J Clin Exp Med 2014; 7: 1808-12.
26. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR and Dickson RB. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 1994; 12: 181-94.
27. Franke WW, Schmid E, Osborn M and Weber K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci U S A 1978; 75: 5034-8.
28. Zhao J, Dong D, Sun L and Zhang G. Prognostic significance of the epithelial-tomesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer. Int Braz J Urol 2014; 40: 179-89.
29. Yamada S, Fuchs BC, Fujii T, Shimoyama Y, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y and Nakao A. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surg 2013; 154: 946-54.